Nuzenio

Protagonist Therapeutics Reports

Protagonist Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Protagonist Therapeutics, Inc. (PTGX) Stock Forecasts - Yahoo! Finance CanadaYahoo! Finance Canada · Sat, 08 Aug 2026 11:42:26 GMT Protagonist Therapeutics (PTGX): State Street discloses 5.2% beneficial ownership stake - Stock TitanStock Titan · Fri, 07 Aug 2026 14:46:41 GMT Analysts Conflicted on These Healthcare Names: Protagonist Therapeutics (PTGX), Qiagen (QGEN) and Envista Holdings (NVST) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 09:03:24 GMT Citigroup Forecasts Strong Price Appreciation for Protagonist Therapeutics (NASDAQ:PTGX) Stock - MarketBeatMarketBeat · Thu, 06 Aug 2026 20:16:33 GMT Protagonist Therapeutics price target raised to $175 from $130 at Citi - TipRanksTipRanks · Thu, 06 Aug 2026 11:12:07 GMT Protagonist Therapeutics, Inc. $PTGX Shares Acquired by California State Teachers Retirement System - MarketBeatMarketBeat · Thu, 06 Aug 2026 08:06:02 GMT Protagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:22:29 GMT Protagonist Therapeutics, Inc 2026: Revenue $213.48M, EPS $2.29— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMT

Timeline

Sat, 08 Aug 2026 11:42:26 GMTProtagonist Therapeutics, Inc. (PTGX) Stock Forecasts - Yahoo! Finance Canada

Fri, 07 Aug 2026 14:46:41 GMTProtagonist Therapeutics (PTGX): State Street discloses 5.2% beneficial ownership stake - Stock Titan

Fri, 07 Aug 2026 09:03:24 GMTAnalysts Conflicted on These Healthcare Names: Protagonist Therapeutics (PTGX), Qiagen (QGEN) and Envista Holdings (NVST) - The Globe and Mail

Thu, 06 Aug 2026 20:16:33 GMTCitigroup Forecasts Strong Price Appreciation for Protagonist Therapeutics (NASDAQ:PTGX) Stock - MarketBeat

Thu, 06 Aug 2026 11:12:07 GMTProtagonist Therapeutics price target raised to $175 from $130 at Citi - TipRanks

Thu, 06 Aug 2026 08:06:02 GMTProtagonist Therapeutics, Inc. $PTGX Shares Acquired by California State Teachers Retirement System - MarketBeat

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Protagonist Therapeutics20 live mentions Inc18 live mentions PTGX16 live mentions NASDAQ6 live mentions Therapeutics4 live mentions PTGX Shares Acquired4 live mentions Revenue4 live mentions Stock Titan Protagonist3 live mentions Stock Titan Stock3 live mentions Titan3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Protagonist Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.